What is Gemigliptin used for? Gemigliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus. Gemigliptin is under investigation in Type 2 Diabetes Mellitus. Gemigliptin has been
What is Gemigliptin used for?
Gemigliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus. Gemigliptin is under investigation in Type 2 Diabetes Mellitus. Gemigliptin has been investigated for the treatment of Cancer and Cisplatin Adverse Reaction.
When should I take Gemigliptin?
Gemigliptin should be taken at the same time every day since this helps you remember to take it.
What is Gemigliptin Zemiglo?
Gemigliptin (brand name: Zemiglo), developed by LG Life Sciences, is a potent, selective, competitive, and long acting DPP-4 inhibitor. Various studies have shown that gemigliptin is an optimized DPP-4 inhibitor in terms of efficacy, safety, and patient compliance for treatment of type 2 diabetes mellitus.
How do you take Zemiglo?
It can be taken with or without food. The dose will depend on your condition and blood sugar levels. Use it strictly as advised by your doctor. Do not stop taking the medicine unless your doctor recommends it.
What are the common side effects of gliclazide?
Common side effects
- stomach ache or indigestion.
- feeling sick (nausea)
- being sick (vomiting) or diarrhoea.
- constipation.
What is another name for linagliptin?
Tradjenta (linagliptin) is an add-on medication to diet and exercise to improve blood sugar control in people with type 2 diabetes.
What is the side effects of metformin?
Side Effects Nausea, vomiting, stomach upset, diarrhea, weakness, or a metallic taste in the mouth may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly. If stomach symptoms return later (after taking the same dose for several days or weeks), tell your doctor right away.
What is normal blood sugar level?
A blood sugar level less than 140 mg/dL (7.8 mmol/L) is normal. A reading of more than 200 mg/dL (11.1 mmol/L) after two hours indicates diabetes. A reading between 140 and 199 mg/dL (7.8 mmol/L and 11.0 mmol/L) indicates prediabetes.
Is linagliptin better than metformin?
In terms of treatment convenience, our data showed that linagliptin was superior to metformin.
When was gemigliptin approved by the Food and Drug Administration?
Gemigliptin (LC15-0444) tartrate sesquihydrate is a potent, selective, competitive, and long-acting DPP-4 inhibitor discovered by modifying compounds from published patents. It was approved by the Korean Food and Drug Administration (KFDA) in June 2012.
How is gemigliptin used in the treatment of diabetes?
Gemigliptin is an organonitrogen compound and an organooxygen compound. It derives from a beta-amino acid. Gemigliptin is under investigation in Type 2 Diabetes Mellitus. Gemigliptin has been investigated for the treatment of Cancer and Cisplatin Adverse Reaction.
What is the effect of gemigliptin on the kidneys?
In addition, gemigliptin exerts a renoprotective effect, probably through enhanced GLP-1 signaling, may prevent apoptosis and acute kidney injury induced by nephrotoxic agents, and may protect against diabetic nephropathy. Gemigliptin is an organonitrogen compound and an organooxygen compound.